![](/img/cover-not-exists.png)
Development of potent pyrazolopyrimidinone-based WEE1 inhibitors with limited single-agent cytotoxicity for cancer therapy
Matheson, Christopher J, Casalvieri, Kimberly A, Backos, Donald S, Reigan, PhilipLanguage:
english
Journal:
ChemMedChem
DOI:
10.1002/cmdc.201800188
Date:
June, 2018
File:
PDF, 5.91 MB
english, 2018